Wesley Self

April 13, 2022

Additional COVID vaccine helps protect transplant patients

Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.

By Nancy Humphrey
Cody Stubblefield, RN, gives the first of two injections of an antibody combination to Caroline Davis to protect her from COVID-19.
February 9, 2022

Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.

By Kristin Smart
Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
January 6, 2022

Grant boosts vaccine effectiveness research

By Nancy Humphrey
July 26, 2021

VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

By Craig Boerner
The study team includes (seated, from left) Adrienne Baughman, CCRP; Bob McClellan; Wesley Self, MD, MPH; Christina Kampe, CCRP; (standing, from left) Rendie McHenry; Bo Stubblefield, MD; Jon Casey, MD, MSCI; Todd Rice, MD, MSc; Natasha Halasa, MD, MPH; Jakea Johnson, MPH; Jim Chappell, MD, PhD; Carlos Grijalva, MD, MPH; and Kelsey Womack, PhD. Not pictured are Julia Rhoads, PhD; Chris Lindsell, PhD; Keipp Talbot; MD, MPH; and Kimberly Hart, MA. (photo by Donn Jones)
March 2, 2021

Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

By Kristin Smart
February 5, 2021

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

By Tom Wilemon
November 9, 2020

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
By Bill Snyder
October 29, 2020

Self named VP for Clinical Research Networks and Strategy

Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.
By VUMC News and Communications
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
By Bill Snyder
October 5, 2020

Treating appendicitis with antibiotics instead of surgery may be good option for some, but not all, patients

Antibiotics instead of surgery may be a good choice for some, but not all, patients with appendicitis, according to results from a study reported today in the New England Journal of Medicine.
By Nancy Humphrey
September 17, 2020

Study finds COVID-19 antibodies drop substantially in the weeks following infection

The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).
By Nancy Humphrey
September 11, 2020

Study shows eating at restaurants may increase COVID-19 risk

Eating at dine-in restaurants appears to increase the risk of becoming sick with COVID-19, according to a recent study by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University Medical Center.
By Nancy Humphrey
September 3, 2020

COVID infections in health workers often go undetected: study

Many COVID-19 infections among health care workers go undetected, likely because many people infected with SARS-CoV-2, the virus that causes COVID-19, have mild or no symptoms, a study led by Vanderbilt University Medical Center’s Wesley Self, MD, MPH, shows.
By Nancy Humphrey
1 2 3 4